These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1799930)

  • 1. Chronopharmacokinetics and cardiovascular effects of nifedipine.
    Lemmer B; Nold G; Behne S; Kaiser R
    Chronobiol Int; 1991; 8(6):485-94. PubMed ID: 1799930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronopharmacology of oral nitrates in healthy subjects.
    Scheidel B; Lemmer B
    Chronobiol Int; 1991; 8(5):409-19. PubMed ID: 1818789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical chronopharmacology of oral sustained-release isosorbide-5-mononitrate in healthy subjects.
    Lemmer B; Scheidel B; Blume H; Becker HJ
    Eur J Clin Pharmacol; 1991; 40(1):71-5. PubMed ID: 2060550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
    Cainazzo MM; Pinetti D; Savino G; Bartiromo M; Forgione A; Bertolini A
    Drugs Exp Clin Res; 2005; 31(3):115-21. PubMed ID: 16033250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronopharmacokinetics: implications for drug treatment.
    Lemmer B
    J Pharm Pharmacol; 1999 Aug; 51(8):887-90. PubMed ID: 10504025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of different oral nifedipine preparations in healthy Brazilian volunteers.
    Vianna-Jorge R; Sudo RT; Melo PA; Suarez-Kurtz G
    Braz J Med Biol Res; 1992; 25(4):385-91. PubMed ID: 1342215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability and pharmacokinetics of nifedipine administered by different routes in healthy volunteers.
    Palma-Aguirre JA; Rosas-Alcázar G; Rodríguez JM; León-Urrea F; Montoya-Cabrera MA
    Arch Invest Med (Mex); 1989; 20(2):129-35. PubMed ID: 2604495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardiovascular system and daily variation in response to antihypertensive and antianginal drugs: recent advances.
    Lemmer B
    Pharmacol Ther; 1991; 51(2):269-74. PubMed ID: 1686113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [24-hour blood pressure decrease with nifedipine with a new galenic action].
    Bühler G; Rosenthal JR; Santak J; Stephanos S; Wadepuhl M
    Fortschr Med; 1992 Feb; 110(4):57-8, 61-2. PubMed ID: 1568692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine.
    Robertson DR; Waller DG; Renwick AG; George CF
    Br J Clin Pharmacol; 1988 Mar; 25(3):297-305. PubMed ID: 3358895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nifedipine: kinetics and dynamics in healthy subjects.
    Kleinbloesem CH; van Brummelen P; van de Linde JA; Voogd PJ; Breimer DD
    Clin Pharmacol Ther; 1984 Jun; 35(6):742-9. PubMed ID: 6734025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and Tolerability Comparison of Sustained and Immediate Release Oral Formulations of Nifedipine Tablet Formulations: A Single-Dose, Randomized, Open-Label, Two-Period, Two-Way Crossover Study in Healthy, Fasting Egyptian Male Volunteers.
    El-Masry SM; El-Khodary NM
    Drug Res (Stuttg); 2020 Feb; 70(2-03):91-96. PubMed ID: 31746448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship.
    Kleinbloesem CH; van Brummelen P; van Harten J; Danhof M; Breimer DD
    Clin Pharmacol Ther; 1985 May; 37(5):563-74. PubMed ID: 3987180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow-release nifedipine: effect on the circadian rhythm of blood pressure in essential hypertension.
    Portaluppi F; degli Uberti E; Strozzi C; Margutti A; Montanari L; Rambaldi R; Trasforini G; Pansini R
    Acta Cardiol; 1987; 42(1):37-47. PubMed ID: 3494367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of food on nifedipine sustained-release preparation.
    Ueno K; Kawashima S; Uemoto K; Ikada T; Miyai K; Wada K; Yamazaki K; Matsumoto K; Nakata I
    DICP; 1989 Sep; 23(9):662-5. PubMed ID: 2800577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation dependent pharmacokinetics--does the dosage form matter for nifedipine?
    Toal CB
    J Cardiovasc Pharmacol; 2004 Jul; 44(1):82-6. PubMed ID: 15175561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and electroencephalographic effects of darodipine 50-200 mg modified release (MR) acute oral administration: dose-finding study in healthy volunteers.
    Sannita WG; Busico S; Di Bon G; Ferrari A; Riela S
    Int J Clin Pharmacol Res; 1993; 13(5):281-91. PubMed ID: 8200723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of slow release nifedipine tablets in patients with essential hypertension.
    Imai Y; Abe K; Munakata M; Sasaki S; Minami N; Sakuma H; Hashimoto J; Watanabe N; Sakuma M; Sekino H
    Arzneimittelforschung; 1992 Dec; 42(12):1434-8. PubMed ID: 1288507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.